Trial intelligence / Profile preview

Seroquel XR and BDNF in Bipolar Disorder

NCT00879307Phase 3Unknown

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Mar 2009
Primary completion
Sep 2011
Countries
1
01

Overview

A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by Hospital de Clínicas de Porto Alegre. Status: unknown.

02

Drugs

quetiapine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00879307.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00879307.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call